Complix's Series A - II Round

Complix raised a round of funding on January 14, 2011. Investors include Omnes Capital.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Series A - II Round: